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Abstract: Here we describe a prediction-based framework to analyze omic data and generate models for 
both disease diagnosis and identification of cellular pathways which are significant in complex diseases. 
Our framework differs from previous analysis in its use of underlying biology (cellular pathways/gene-
sets) to produce predictive feature-disease models. In our study of alcoholism, lung cancer, and 
schizophrenia, we demonstrate the framework’s ability to robustly analyze omic data of multiple types 
and sources, identify significant features sets, and produce accurate predictive models. 
We found novel significant pathways for each disease and developed models with predictive powers of 
83%, 81%, and 76%, respectively for the three diseases. This is thus the first ‘good’ predictor of alcohol 
dependence [1]. Our higher consistency between analyses of multiple datasets demonstrates that our 
method is robust. This enables intervention when the onset of alcoholism or schizophrenia appears 
likely, and can help us better understand underlying biological mechanisms and risk factors. 
Introduction 
The rapid accumulation of high-throughput genomic and proteomic data has offered unprecedented 
opportunities for biologists to gain insights into disease. Here we demonstrate a robust, prognostic 
framework to identify biologically meaningful feature sets and develop predictive models for disease.  
Method 
We first develop Bayesian models linking each feature in a pathway to the disease phenotype, via a 
curated SNP-gene-pathway mapping. Then, our method sorts the models based on accuracy as a 
phenotypic classifier, identifying models and corresponding feature sets with significant predictive 
accuracy. From this, we identified disease-significant pathways and eliminated the necessity for 
background gene selection. Using the best performing feature-sets in a final model, we created an 
aggregate prognostic model for each disease. Three multifactorial diseases were studied: alcoholism 
(SNP data), lung cancer (gene expression data), and schizophrenia (SNP data from a differing chip 
platform). For each disease, we independently analyzed two data sets (        and 1367) to understand 
the method’s robustness. 
Results and Discussion 
In our study of alcoholism, we identified four clinically-ascertainable pathways that have not been 
previously tied to the behavior. These pathways were common to our analysis results of our two 
alcoholism data-sets.  The aggregate model of these gene-sets yielded the first ‘good’ predictive model of 
alcoholism (AUC = .83) when testing on a merged dataset. In our second study, studying lung cancer, 
we found seven pathways common significant pathways and produced an aggregate model (AUC of .81). 
Our significant pathway results from lung cancer exhibited higher percentages of than cross-data 
overlap than a corresponding one done in the seminal 2005 GSEA paper. In our final study, for 
schizophrenia, we identified three novel gene sets significant to the disease and developed a fair 
aggregate predictive model (AUC = .76). 
The power of our predictive enrichment framework lies in its biological meaning (bases models on the 
studied pathway biology in order to draw further insight), robustness, and flexibility – the choice of data 
modality, predictive structures, choice of feature sets, and the number of central phenotypic outcomes.  
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